Autopsy report · NCT02124785

Evaluation of the Long-term Persistence of Hepatitis A Antibodies in Healthy Adults Who Were Vaccinated 21-25 Years Earlier With GlaxoSmithKline (GSK) Biologicals' Hepatitis A Vaccine, Havrix®

“This study has been cancelled before initiation due to company's prioritisation decisions linked to resources restrictions.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 4

Sponsor

GlaxoSmithKline

Sponsor type

Industry

Conditions

Hepatitis A

Interventions

Blood sampling

Participants

0

Sites

1

Countries

Belgium

Trials that died the same way

• Study to Evaluate the Safety, Tolerability, and Efficacy of ASC41 in Adults With NASH
  “This study has been cancelled due to business reasons” (73% match in meaning)
• Study of Select Combinations in Adults With Myelofibrosis
  “This study was cancelled before enrolling any patients for business related reasons.” (70% match in meaning)
• Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis
  “This study was terminated early due to company decision.” (68% match in meaning)
• Phase 2a Study Examining the Safety and Efficacy of BOL-DP-o-04 for Treating Diabetic Neuropathy
  “study stopped due to company strategic prioritization” (67% match in meaning)
• Study Evaluating the Efficacy and Safety of IPI 504 in Patients With Advanced Dedifferentiated Liposarcoma
  “Company decision not to start the study” (67% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.